NL7003420A - - Google Patents

Info

Publication number
NL7003420A
NL7003420A NL7003420A NL7003420A NL7003420A NL 7003420 A NL7003420 A NL 7003420A NL 7003420 A NL7003420 A NL 7003420A NL 7003420 A NL7003420 A NL 7003420A NL 7003420 A NL7003420 A NL 7003420A
Authority
NL
Netherlands
Application number
NL7003420A
Other versions
NL167724B (nl
NL167724C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7003420A publication Critical patent/NL7003420A/xx
Publication of NL167724B publication Critical patent/NL167724B/xx
Application granted granted Critical
Publication of NL167724C publication Critical patent/NL167724C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
NL7003420A 1969-10-13 1970-03-10 Werkwijze voor het kweken van een streptococcus faecium -stam, werkwijze voor het bereiden van een preparaat dat deze streptococcus feacium-stam bevat en werkwijze voor het verbeteren van de groei van huisdieren. NL167724C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE6913996A SE371209B (cg-RX-API-DMAC7.html) 1969-10-13 1969-10-13

Publications (3)

Publication Number Publication Date
NL7003420A true NL7003420A (cg-RX-API-DMAC7.html) 1971-04-15
NL167724B NL167724B (nl) 1981-08-17
NL167724C NL167724C (nl) 1982-01-18

Family

ID=20298361

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003420A NL167724C (nl) 1969-10-13 1970-03-10 Werkwijze voor het kweken van een streptococcus faecium -stam, werkwijze voor het bereiden van een preparaat dat deze streptococcus feacium-stam bevat en werkwijze voor het verbeteren van de groei van huisdieren.

Country Status (14)

Country Link
US (1) US3713836A (cg-RX-API-DMAC7.html)
JP (1) JPS5038682B1 (cg-RX-API-DMAC7.html)
AT (1) AT296923B (cg-RX-API-DMAC7.html)
BE (1) BE747129A (cg-RX-API-DMAC7.html)
CA (1) CA933409A (cg-RX-API-DMAC7.html)
CH (1) CH542281A (cg-RX-API-DMAC7.html)
DE (1) DE2010654C3 (cg-RX-API-DMAC7.html)
ES (1) ES377347A1 (cg-RX-API-DMAC7.html)
FR (1) FR2068543A1 (cg-RX-API-DMAC7.html)
GB (1) GB1300446A (cg-RX-API-DMAC7.html)
IT (1) IT1142151B (cg-RX-API-DMAC7.html)
LU (1) LU60508A1 (cg-RX-API-DMAC7.html)
NL (1) NL167724C (cg-RX-API-DMAC7.html)
SE (1) SE371209B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271364A3 (en) * 1986-12-12 1988-10-26 Biorem C.C. Preparation suitable for treating enteric disorders

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
GB2077101B (en) * 1980-05-12 1984-08-08 Kyokuto Fatty Acid Corp Antiallergic composition containing streptococci
EP0180743B1 (de) * 1984-09-21 1991-11-06 Cernitin S.A. Lebende Mikroorganismen enthaltendes flüssiges Präparat, Verfahren zu dessen Herstellung, lebende Mikroorganismen enthaltendes pelletiertes Produkt und Verfahren zu dessen Herstellung
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
AT383956B (de) * 1985-10-11 1987-09-10 Mirimi Erzeugungs Handels Und Verwendung eines neuen stammes von streptococcus faecium bakterien zur absenkung des ph-wertes im magen-darm-trakt von tieren, sowie der neue stamm selbst
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
AU640349B2 (en) * 1988-08-02 1993-08-26 Borody, Thomas J Dr Treatment of gastro-intestinal disorders
WO1990001335A1 (en) * 1988-08-02 1990-02-22 Borody Thomas J Treatment of gastro-intestinal disorders
US5529793A (en) * 1994-11-16 1996-06-25 Nutrition Physiology Corporation Compositions for improving the utilization of feedstuffs by ruminants
US5534271A (en) * 1994-11-16 1996-07-09 Nutrition Physiology Process for improving the utilization of feedstuffs by ruminants
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
RU2205216C2 (ru) * 2000-10-10 2003-05-27 Морозов Василий Юрьевич Штамм бактерий enterococcus faecium в-2240d - продуцент оптически чистой l(+)-молочной кислоты и промышленный способ получения l(+)-молочной кислоты или ее солей
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
AU2003300208A1 (en) * 2003-01-06 2004-08-10 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
US20050048515A1 (en) * 2003-08-29 2005-03-03 Garner Bryan E. Methods for detecting and quantifying specific probiotic microorganisms in animal feed
AU2004269388B2 (en) * 2003-08-29 2009-09-17 Nutrition Physiology Company, Llc. Methods for detecting and quantifying specific microorganisms
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN103561752B (zh) 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
WO2016183577A1 (en) 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN108243608A (zh) 2015-05-22 2018-07-03 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11492587B2 (en) 2017-01-31 2022-11-08 Kansas State University Research Foundation Microbial cells, methods of producing the same, and uses thereof
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020513018A (ja) 2017-04-05 2020-04-30 クレストヴォ・ホールディングス・エルエルシー パーキンソン病(pd)および関連する障害を治療するための組成物および方法
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
WO2019079764A1 (en) 2017-10-20 2019-04-25 Ms Biotech, Inc. METHODS FOR PRODUCING PLANT MATERIALS EMITTED WITH MEGASPHAERA ELSDENII
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
BR112022000875A2 (pt) 2019-07-19 2022-03-29 Finch Therapeutics Holdings Llc Métodos e produtos para tratamento de distúrbios gastrointestinais

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271364A3 (en) * 1986-12-12 1988-10-26 Biorem C.C. Preparation suitable for treating enteric disorders

Also Published As

Publication number Publication date
BE747129A (fr) 1970-08-17
AT296923B (de) 1972-02-15
CH542281A (de) 1973-09-30
LU60508A1 (cg-RX-API-DMAC7.html) 1970-05-11
DE2010654B2 (de) 1979-06-28
CA933409A (en) 1973-09-11
IT1142151B (it) 1986-10-08
FR2068543A1 (cg-RX-API-DMAC7.html) 1971-08-27
DE2010654A1 (de) 1971-05-06
JPS5038682B1 (cg-RX-API-DMAC7.html) 1975-12-11
NL167724B (nl) 1981-08-17
NL167724C (nl) 1982-01-18
ES377347A1 (es) 1973-04-16
US3713836A (en) 1973-01-30
SE371209B (cg-RX-API-DMAC7.html) 1974-11-11
DE2010654C3 (de) 1980-03-06
GB1300446A (en) 1972-12-20

Similar Documents

Publication Publication Date Title
JPS5038682B1 (cg-RX-API-DMAC7.html)
AU465452B2 (cg-RX-API-DMAC7.html)
AU4221168A (cg-RX-API-DMAC7.html)
AU450150B2 (cg-RX-API-DMAC7.html)
AU2355770A (cg-RX-API-DMAC7.html)
AU470301B1 (cg-RX-API-DMAC7.html)
AU5113869A (cg-RX-API-DMAC7.html)
AU425297B2 (cg-RX-API-DMAC7.html)
AT308690B (cg-RX-API-DMAC7.html)
AU417208B2 (cg-RX-API-DMAC7.html)
AU438128B2 (cg-RX-API-DMAC7.html)
AU414607B2 (cg-RX-API-DMAC7.html)
AU410358B2 (cg-RX-API-DMAC7.html)
AU428074B2 (cg-RX-API-DMAC7.html)
AU470661B1 (cg-RX-API-DMAC7.html)
CS150483B1 (cg-RX-API-DMAC7.html)
AU4923469A (cg-RX-API-DMAC7.html)
AR203167Q (cg-RX-API-DMAC7.html)
AU5079269A (cg-RX-API-DMAC7.html)
CS150357B1 (cg-RX-API-DMAC7.html)
AU5109569A (cg-RX-API-DMAC7.html)
AU1036070A (cg-RX-API-DMAC7.html)
AU5228269A (cg-RX-API-DMAC7.html)
AU5598769A (cg-RX-API-DMAC7.html)
BE749642A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent